CA2051695A1 - Glutathion-s-transferase sm26 du s. mansoni - Google Patents

Glutathion-s-transferase sm26 du s. mansoni

Info

Publication number
CA2051695A1
CA2051695A1 CA002051695A CA2051695A CA2051695A1 CA 2051695 A1 CA2051695 A1 CA 2051695A1 CA 002051695 A CA002051695 A CA 002051695A CA 2051695 A CA2051695 A CA 2051695A CA 2051695 A1 CA2051695 A1 CA 2051695A1
Authority
CA
Canada
Prior art keywords
protein
sequence
residue
amino acid
ending
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002051695A
Other languages
English (en)
French (fr)
Inventor
Francois Trottein
Andre Capron
Doris Schmitt
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2051695A1 publication Critical patent/CA2051695A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002051695A 1990-02-07 1991-02-06 Glutathion-s-transferase sm26 du s. mansoni Abandoned CA2051695A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9001403A FR2657883A1 (no) 1990-02-07 1990-02-07
FR90/01403 1990-02-07

Publications (1)

Publication Number Publication Date
CA2051695A1 true CA2051695A1 (fr) 1991-08-08

Family

ID=9393459

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002051695A Abandoned CA2051695A1 (fr) 1990-02-07 1991-02-06 Glutathion-s-transferase sm26 du s. mansoni

Country Status (7)

Country Link
EP (1) EP0466912A1 (no)
JP (1) JPH04505402A (no)
KR (1) KR920701445A (no)
AU (1) AU645786B2 (no)
CA (1) CA2051695A1 (no)
FR (1) FR2657883A1 (no)
WO (1) WO1991012327A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2745695A (en) * 1994-06-22 1996-01-15 Imperial College Of Science, Technology And Medicine Schistosoma protein and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU613583B2 (en) * 1986-08-22 1991-08-08 Transgene S.A. Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
WO1990008819A1 (en) * 1989-01-31 1990-08-09 Daratech Pty. Ltd. Vaccine for the preventative treatment of infection of liver fluke in ruminants

Also Published As

Publication number Publication date
EP0466912A1 (fr) 1992-01-22
WO1991012327A1 (fr) 1991-08-22
AU645786B2 (en) 1994-01-27
AU7333391A (en) 1991-09-03
FR2657883A1 (no) 1991-08-09
JPH04505402A (ja) 1992-09-24
KR920701445A (ko) 1992-08-11

Similar Documents

Publication Publication Date Title
US4900673A (en) Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
CN114430744B (zh) 抗Tau抗体及其用途
Jones et al. Expression and structural analysis of 14-3-3 proteins
DK172463B1 (da) Anvendelse af oncostatin-A eller derivater deraf til in vitro diagnostisk detektion af tumorceller
EP0293357B1 (fr) Expression de la proapolipoprotéine A-I humaine
KR100629185B1 (ko) 인간 리조포스파티드산 수용체 물질 및 그 용도
JP2000509967A (ja) カルシウムチャンネルモジュレーターとして活性のあるアセチルコリンエステラーゼの可溶形態からのペプチド
AU589598B2 (en) Brain derivable polypeptide factors and antibodies
JPH11500312A (ja) ＮＦ−κＢの活性化制御蛋白、ＩκＢ−β
CA2113202A1 (en) Neural calcium-activated neutral proteinase inhibitors
CA2051695A1 (fr) Glutathion-s-transferase sm26 du s. mansoni
US20050069557A1 (en) Vertebrate globin
WO1994029448A1 (fr) Adn et proteine codee par celui-ci
uan Fan et al. Antibodies to cytoplasmic dynein heavy chain map the surface and inhibit motility
US6794500B2 (en) RNA-binding protein
US4963485A (en) Brain derivable polypeptide factors and antibodies thereto
US5011777A (en) Vectors encoding brain derivable polypeptide factors
US20020173475A1 (en) Methods to inhibit viral replication
JP2001507226A (ja) 有糸分裂を調節するためのタンパク質および組成物
US5661003A (en) Water channel
KR100233962B1 (ko) 포스포리파제 c-베타4를 인지하는 단클론성 항체와 이를 분비하는 융합 세포주
JPH03173899A (ja) 生体由来のタンパク質
FR2848566A1 (fr) Peptides epitopiques de l'enzyme thyroperoxydase, les compositions les contenant et leurs applications
CN1375007A (zh) 编码一种新的苏氨酰转移核糖核酸合成酶的基因及其应用和制备方法
WO2000007614A1 (fr) Remèdes contre les maladies de dégénérescence nerveuse

Legal Events

Date Code Title Description
FZDE Dead